By George Stahl 
 

Johnson & Johnson (JNJ) received a favorable verdict Thursday from a Texas jury in a trial regarding the company's all-metal hip-implant product.

The company was found not liable in a suit concerning Ultamet's metal-on-metal hip-replacement product, made by J&J's DePuy unit. Sales of the product were discontinued in May 2013 because of low demand and alternative hip products.

In a statement, a DePuy spokeswoman said the company was pleased with the jury's decision.

The jury verdict represented the first one in this round of litigation.

As of June 29, about 6,600 lawsuits involving Ultamet had been filed in state and federal court, most of which have been coordinated in the U.S. District Court for the Northern District of Texas.

J&J, which expects additional cases to be tried in the coming months, has said it is committed to fighting the allegations.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Johnson and Johnson Charts.